Differential potentiation of L-tryptophan-induced head-twitch response in mice by cocaine and sertraline

Life Sciences

Volumn 59, Issue 14, 1996, Pages 1109-1119

  Darmani, Nissar A ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

cocaine; GBR 12935; head twitch response; L tryptophan; nisoxetine; sertraline

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 5 HYDROXYTRYPTOPHAN; ALPHA 2 ADRENERGIC RECEPTOR; COCAINE; DOPAMINE UPTAKE INHIBITOR; MONOAMINE OXIDASE INHIBITOR; NISOXETINE; PRESYNAPTIC RECEPTOR; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRYPTOPHAN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG POTENTIATION; HEAD TWITCH; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; SEROTONINERGIC SYSTEM;

ANIMALIA;

EID: 0030606835     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00428-6     Document Type: Article

References (63)

1. 1. N.A. DARMANI, B.R. MARTIN, U. PANDEY and R.A. GLENNON, Pharmacol. Biochem. Behav. 36 901-906 (1990).
2. 2. R. SCHREIBER, M. BROCCO, V. AUDINOT, A. GOBERT, S. VEIGA and M. MILLAN, J. Pharmacol. Exp. Therap. 273 101-112 (1995).
3. 3. N.A. DARMANI, B.R. MARTIN, U. PANDEY and R.A. GLENNON, Pharmacol. Biochem. Behav. 38 353-357 (1991).
4. 4. N.A. DARMANI, B.R. MARTIN, U. PANDEY and R.A. GLENNON, Pharmacol. Biochem. Behav. 41 519-527 (1992).
5. 5. N.A. DARMANI and S.L. REEVES, Pharmacol. Biochem. Behav. In press.
6. 6. W.D. ESSMAN, A. SINGH and I. LUCKI, Pharmacol. Biochem. Behav. 49 107-113 (1994).
7. 7. M.C. RITZ, R.J. LAMB, S.R. GOLDBERG and M.J. KUHAR, Science 237 1219-1223 (1987).
8. 8. M.J. KUHAR, M.C. RITZ, D. GRIGORIADIS, R. LEW and J. SHARKEY, Cocaine, Pharmacology, Physiology and Clinical Strategies, J.M. Lakoski, M.P. Galloway and F.J. White (Eds), 191-201, CRC Press, Boca Raton, Florida (1992).
9. 9. M.E.A. REITH, B.E. MEISLER, H. SERSHEN and A. LAJTHA, Brain Res. 342 145-148 (1985).
10. 10. P.A. BRODERICK, Pharmacol. Biochem. Behav. 40 959-968 (1991).
11. 11. N.-H. CHEN and M.E.A. REITH, J. Neurochem. 63 1701-1713 (1994).
12. 12. S. BENLOUCIF and M.P. GALLOWAY, Eur. J. Pharmacol. 200 1-8 (1991).
13. 13. P.A. BRODERICK, E.P. KORNAK, F. ENG. and R. WECHSLER, Pharmaocl. Biochem. Behav. 46 715-722 (1993).
14. 14. A. McGREGOR, S. LACOSTA and D.C.S. ROBERTS, Pharmacol. Biochem. Behav. 44 651-655 (1993).
15. 15. M.E. CARROLL, S.T. LAC, M. ASENCIO and R. KARGH, Psychopharmacology (Berlin) 100 293-300 (1990).
16. 16. M.E. CARROLL, S.T. LAC, M. ASENCIO and R. KARGH, Pharmacol. Biochem. Behav. 35 237-244 (1990).
17. 17. N.R. RICHARDSON and D.C.S. ROBERTS, Life Sci. 49 833-840 (1991).
18. 18. A. MATTIA, A.P. LECESSE and J.E. MORTON, Pharmacologist 28 151-156 (1986).
19. 19. B.A. McMILLAN, E.A. JONES, L.A. HILL, H.L. WILLIAMS, A. BJÖRK and R.D. MYERS, Pharmaocl. Biochem. Behav. 46 125-129 (1993).
20. 20. T.F. MEERT and P.A.J. JANSSEN, Drug Dev. Res. 25 39-53 (1992).
21. 21. S. KNAPP and A.J. MANDELL, Science 177 1209-1211 (1972).
22. 22. E. FRIEDMAN, S. GERSHON, and J. ROTROSEN, Br. J. Pharmacol. 54 61-64 (1975).
23. 23. M.P. GALLOWAY, Synapse 6 63-72 (1990).
24. 24. J.P. EBLE and C. GOODRICH, Physiol. Behav. 41 47-51 (1987).
25. 25. A.J. SLEIGHT, C.A. MARSDEN, K.F. MARTIN and M.G. PALFREYMAN, Br.J. Pharmacol. 93 303-310 (1988).
26. 26. D. MURDOCH and D. McTAVISH, Drugs 44 604-624 (1992).
27. 27. S.M. TEJANI-BUTT, D.J. BRUNSWICK and A. FRAZER, Eur. J. Pharmacol. 191 239-243 (1990).
28. 28. M.E.A. REITH, B. DE COSTA, K.C. RICE and A.E. JACOBSON, Eur. J. Pharmacol. 227 417-425 (1992).
29. 29. T.W. STONE, Pharmacol. Rev. 45 309-379 (1993).
30. 30. A. CARLSSON and M. LINDQVIST, Naunyn-Schmied. Arch Pharmacol. 303 157-164 (1978).
31. 31. K.J. LOOKINGLAND, N.J. SHANNON, D.S. CHAPEN and K.E. MOORE, J. Neurochem. 47 205-212 (1986).
32. 32. D.G. GRAHAME-SMITH, Ad. Biochem. Psychopharmac. 10 83-91 (1974).
33. 33. S. AUERBACH and P. LIPTON, J. Neurochem. 44 1116-1130 (1985).
34. 34. J. D. SCHAECHTER and R.J. WURTMAN, Brain Res. 532 203-210 (1990).
35. 35. Q. PEI, T. ZETTERSTROM and M. FILLENZ, Neurochem. Int. 15 503-509 (1989).
36. 36. T. SHARP, S.R. BRAMWELL and D.G. GRAHAME-SMITH, Life Sci. 50 1215-1223 (1992).
37. 37. M.G. DE SIMONI, A. SOKOLA, F. FODRITTO, G. DAL TOSO and S. ALGERI, Brain Res. 411 89-94 (1987).
38. 38. D.G. GRAHAME-SMITH, J. Neurochem. 18 1053-1056 (1971).
39. 39. D.M. KUHN, W.A. WOLF and M.B.H. YOUDIM, Neurochem. Int. 8 141-154 (1986).
40. 40. J.P.M. FINBERG and M.B.H. YOUDIM, Neuropharmacology 22 441-446 (1983).
41. 41. C.J. FOWLER and K.F. TIPTON, J. Neurochem. 38 733-736 (1982).
42. 42. K.N. WESTLUND, R.M. DENNY, L.M. KOCHERSPERGER, R.M. ROSE and C.W. ABELL, Science 230 181-183 (1985).
43. 43. K.N. WESTLUND, R.M. DENNY, L.M. ROSE and C. ABELL, Neuroscience 25 439-456 (1988).
44. 44. C. KONRADI, J. KORNHUBER, L. FROELICH, J. FRITZE, H. HEINSEN, H. BECKMAN, E. SCHULTZ and P. RIEDERER, Neuroscience 33 383-400 (1989).
45. 45. J. SAURA, R. KETTLER, M. DA PRADA and J.G. RICHARDS, J. Neuroscience 12 1977-1999 (1992).
46. 46. J. WILLOGHBY, V. GLOVER and M. SANDLER, J. Neural Trans. 74 29-42 (1988).
47. 47. P. LEVITT, J.E. PINTAR and X.O. BREAKFIELD, Proc. Natl. Acad. Sci. USA 79 6385-6389 (1982).
48. 48. C. MARUKI, M. SPATZ, Y. UEKI, I. NAGATSU and J. BEMBRY, J. Neurochem. 43 316-319 (1984).
49. 49. M.H. FERNSTROM, M.S. MASSOUDI and J.D. FERNSTROM, Life Sci. 47 283-289 (1990).
50. 50. A. FERRER AND F. ARTIGAS, Eur. J. Pharmacol. 263 227-234 (1994).
51. 51. P.A. BRODERICK and J.A. JACOBY, Diabetis 37 956-960 (1985).
52. 52. E. CARBONI, C. CADONI, G.L. TANDA and G. DI CHIARA, J. Neurochem. 53 976-978 (1989).
53. 53. B.H.C. WESTERINK and J.G. DE VRIES, J. Neurochem. 56 228-233 (1991).
54. 54. M. SALTER, R. HAZELWOOD, C.I. POGSON, R. IYER, D.J. MADGE, H. JONES, B.R. COOPER, R.F. COX, C.M. WANG and R.P. WIARD, Neuropharmacology 34 217-227 (1995).
55. 55. R.B. HOLMAN, E. SEAGRAVES, G.R. ELLIOT and J.D. BARCHAS, Behav. Biol. 16 507-514 (1976).
56. 56. R.W. FULLER, K.W. PERRY and B.B. MOLLOY, Life Sci. 15 1161-1171 (1974).
57. 57. E.C. HWANG, I. MAGNUSSEN and M.H. VAN WOERTH, Res. Commun. Chem. Pathol. 29 79-98 (1980).
58. 58. L. BJÖRK, L.J. CORNFIELD, D.L. NELSON, S.-E. HILLVER, N.-E. ANDEN, T. LEWANDER and U. HACKSELL, J. Pharmacol. Exp. Therap. 258 58-65 (1991).
59. 59. N.A. DARMANI and S.L. REEVES, Pharmacol. Biochem. Behav. In press.
60. 60. S. HJÖRTH, J. Neurochem. 60 776-779 (1993).
61. 61. L. ROMERO, P. CELADA and F. ARTIGAS, Eur. J. Pharmacol. 265 103-106 (1994).
62. 62. F.D. YOCCA, R.N. WRIGHT, R.R. MARGRAF and A.S. EISON, Pharmacol. Biochem. Behav 35 252-254 (1990).
63. 63. N.A. DARMANI, Pharmacol. Biochem. Behav. 49 229-232 (1994).